- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Devices harness unique features enabled by nanoelectronics resulting in ultra-sensitive, accurate and selective measurement of chemicals and bio molecules
Nanomix Incorporated, a leading nanotechnology company commercializing nanoelectronic detection devices for industrial and biomedical applications, announced today the issuance of a U.S. patent for its nanostructured detection platform known as Sensation.
The patent includes broad claims related to nanostructured detection devices. These devices harness unique features enabled by nanoelectronics resulting in ultra-sensitive, accurate and selective measurement of chemicals and bio molecules. The devices have extremely low power requirements and are scalable for mass production in a variety of product applications.
"We are pleased with our emerging patent portfolio related to nanoelectronic detection, which supports our primary business focus," said David Macdonald, President and CEO of Nanomix. "These advancements open up a wide range of applications and commercial opportunities. As the first company to bring a nanoelectronic product to market, we are excited to be at the leading edge of this promising industry. In addition to our own products, we are currently pursuing a number of collaborations for the commercial deployment of Sensation technology."
This patent (US Patent No. 6,894,359, issued May 17, 2005) is the first to be issued in Nanomix' growing portfolio of pending patent applications for the Sensation detection platform and its industrial and biomedical uses. This follows the issuance of three previous patents related to Nanomix' hydrogen storage technology.
Nanomix is a leading nanotechnology company launching a menu of devices based on Sensation™ detection technology. These scaleable, nanoelectronic devices use ultra-sensitive carbon nanotube sensing elements combined with proprietary chemistry and silicon. These devices can be deployed across a broad range of industrial and medical applications where the attributes of nanotechnology - low power consumption, small size, and high sensitivity offer significant performance advantages and enable unprecedented access to critical information.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Electrically Conductive Graphene Ink Enables Printing of Biosensors April 23rd, 2016
Highlights from the Graphene Flagship April 22nd, 2016
The intermediates in a chemical reaction photographed 'red-handed' Researchers at the UPV/EHU-University of the Basque Country have for the first time succeeded in imaging all the steps in a complex organic reaction and have resolved the mechanisms that explain it May 4th, 2016
FEI Launches Apreo – Industry-Leading Versatile, High-Performance SEM: The Apreo SEM provides high-resolution surface information with excellent contrast, and the flexibility to accommodate a large range of samples, applications and conditions May 4th, 2016
Correction: Solar fuels: Protective layer for the 'artificial leaf' March 22nd, 2016